Literature DB >> 18719340

Low prevalence of metabolic syndrome and its components in rural Japan.

Aya Morimoto1, Rimei Nishimura, Naho Suzuki, Toru Matsudaira, Kentaro Taki, Daisuke Tsujino, Yumi Miyashita, Futoshi Ebara, Shinichiro Ishikawa, Naoko Tajima.   

Abstract

Tsunan, Niigata is a non-westernized rural Japanese town, known for heavy snowfalls and as a rice-producing area, whose inhabitants have a long life expectancy. We investigated the prevalence of obesity, metabolic syndrome (MetS) and its components in Tsunan. A total of 1,155 men and women, 40-69 years of age were recruited from participants in the 2005 public-health program in Tsunan. Obesity was defined as body-mass index (BMI) >or= 25 kg/m(2). MetS was defined as BMI >or= 25 kg/m(2) as well as at least two of the following three items: (1) high glycosylated hemoglobin (HbA1c >or= 5.5%); (2) high blood pressure (HBP: systolic blood pressure >or= 130 mmHg or diastolic blood pressure >or= 85 mmHg), and (3) low high-density lipoprotein cholesterol (HDL-C < 40 mg/dL). If an individual was diagnosed with diabetes, hypertension, or dyslipidemia, each item was recorded as a positive finding. The prevalence of MetS and its components among Tsunan inhabitants were compared to the results of the 2005 Japanese nationwide survey. The prevalence of MetS was 4.6% in males and 4.2% in females. The prevalence of obesity, high HbA1c, HBP, and low HDL-C were 22.1/22.2%, 13.4/16.4%, 46.6/40.0%, and 9.2/3.9% in males/females, respectively. All values were significantly lower than the national results, except for the rate of female obesity. The lower prevalence of MetS and its components in Tsunan may be due to the consumption of traditional Japanese food, which is still commonly eaten there, and the higher levels of regular physical activity of farmers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18719340     DOI: 10.1620/tjem.216.69

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  7 in total

1.  Variations in the eicosapentaenoic acid-arachidonic acid ratio associated with age in acute myocardial infarction patients undergoing primary percutaneous coronary intervention.

Authors:  Keisuke Nakabayashi; Kentaro Jujo; Yuho Furuki; Issei Ishida; Hiroshi Ando; Minoru Shimizu; Nobuhisa Hagiwara; Katsumi Saito
Journal:  Heart Vessels       Date:  2018-11-14       Impact factor: 2.037

2.  Prevalence and characteristics of the metabolic syndrome among newly diagnosed hypertensive patients.

Authors:  Charles U Osuji; Emeka G Omejua
Journal:  Indian J Endocrinol Metab       Date:  2012-03

3.  The metabolic syndrome: prevalence, associated factors, and impact on survival among older persons in rural Bangladesh.

Authors:  Masuma Akter Khanam; Chengxuan Qiu; Wietze Lindeboom; Peter Kim Streatfield; Zarina Nahar Kabir; Åke Wahlin
Journal:  PLoS One       Date:  2011-06-15       Impact factor: 3.240

4.  Prevalence of metabolic syndrome in adult population from zahedan, southeast iran.

Authors:  Ma Kaykhaei; M Hashemi; B Narouie; A Shikhzadeh; M Jahantigh; E Shirzaei; B Rezazehi; M Hoseinian; S Yousefi; S Masoudian; A Emamdadi; Sf Alavi; R Mashhadi; H Ansari
Journal:  Iran J Public Health       Date:  2012-02-29       Impact factor: 1.429

Review 5.  Data mining for the identification of metabolic syndrome status.

Authors:  Apilak Worachartcheewan; Nalini Schaduangrat; Virapong Prachayasittikul; Chanin Nantasenamat
Journal:  EXCLI J       Date:  2018-01-10       Impact factor: 4.068

6.  Metabolic syndrome among type 2 diabetic patients in Ethiopia: a cross-sectional study.

Authors:  Mequanent Kassa Birarra; Dessalegn Asmelashe Gelayee
Journal:  BMC Cardiovasc Disord       Date:  2018-07-17       Impact factor: 2.298

7.  Farm working experience could reduce late-life dependency duration among Japanese older adults: The Yamanashi Healthy-Active Life Expectancy cohort study based on the STROBE guidelines.

Authors:  Kayo Haruyama; Hiroshi Yokomichi; Zentaro Yamagata
Journal:  Medicine (Baltimore)       Date:  2020-09-18       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.